ADMA BIOLOGICS INC (ADMA) Stock Earnings & Estimates
NASDAQ:ADMA - US0008991046 - Common Stock
17.26 USD
-0.12 (-0.69%)
17.0532 USD
-0.21 (-1.2%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 154.1M 90.48% | 258.215M 67.56% | 426.454M 65.15% | 516.35M 21.08% | 650.48M 25.98% | 830.81M 27.72% | 1.016B 22.29% | 1.187B 16.83% | 1.226B 3.29% | 1.206B -1.63% | 1.223B 1.41% | |
| EBITDA YoY % growth | -32.19M 39.15% | 32.734M 201.69% | 147.028M 349.16% | 222.69M 51.46% | 321.26M 44.26% | 410.71M 27.84% | 559.01M 36.11% | 682.48M 22.09% | 803.56M 17.74% | N/A | N/A | |
| EBIT YoY % growth | -39.3M 32.71% | 24.402M 162.09% | 138.983M 469.56% | 183.49M 32.02% | 283.06M 54.26% | 385.85M 36.31% | 517.04M 34.00% | 608.06M 17.60% | 690M 13.48% | 632.71M -8.30% | 642.19M 1.50% | |
| Operating Margin | -25.50% | 9.45% | 32.59% | 35.54% | 43.52% | 46.44% | 50.89% | 51.23% | 56.28% | 52.46% | 52.51% | |
| EPS YoY % growth | -0.31 40.38% | -0.13 58.06% | 0.50 484.62% | 0.58 16.79% | 0.92 58.08% | 1.25 35.64% | 1.62 29.12% | 2.00 23.97% | 2.38 18.83% | 1.84 -22.91% | 1.87 1.67% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.16 4.26% | 0.18 28.72% | 0.19 76.18% | 0.21 53.00% | 0.24 53.26% | 0.26 44.34% |
| Revenue Q2Q % growth | 133.82M 11.67% | 139.91M 19.02% | 149.33M 30.08% | 157.39M 29.03% | 166.52M 24.44% | 175.8M 25.65% |
| EBITDA Q2Q % growth | 62.781M 37.26% | 71.298M 53.77% | 74.154M 101.23% | 83.232M 77.75% | 93.33M 48.66% | 106.39M 49.22% |
| EBIT Q2Q % growth | 49.98M 26.09% | 57.12M 49.05% | 62.628M 79.55% | 69.156M 61.59% | 75.735M 51.53% | 82.62M 44.64% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 0.14 7.69% | 0.14 | 0.00 | -1.96% |
| Q1 2025 Q2Q % growth | 0.11 37.50% | 0.16 | -0.05 | -31.17% |
| Q4 2024 Q2Q % growth | 0.14 275.00% | 0.15 | -0.01 | -8.50% |
| Q3 2024 Q2Q % growth | 0.15 1,400.00% | 0.13 | 0.02 | 13.12% |
| Q2 2024 Q2Q % growth | 0.13 533.33% | 0.08 | 0.05 | 59.31% |
| Q1 2024 Q2Q % growth | 0.08 366.67% | 0.06 | 0.02 | 42.60% |
| Q4 2023 Q2Q % growth | -0.08 -33.33% | 0.03 | -0.11 | -413.73% |
| Q3 2023 Q2Q % growth | 0.01 112.50% | -0.01 | 0.02 | 230.72% |
| Q2 2023 Q2Q % growth | -0.03 57.14% | -0.03 | 0.00 | -17.65% |
| Q1 2023 Q2Q % growth | -0.03 70.00% | -0.04 | 0.01 | 30.80% |
| Q4 2022 Q2Q % growth | -0.06 33.33% | -0.06 | 0.00 | 5.88% |
| Q3 2022 Q2Q % growth | -0.08 38.46% | -0.08 | 0.00 | -1.20% |
| Q2 2022 Q2Q % growth | -0.07 50.00% | -0.08 | 0.01 | 14.22% |
| Q1 2022 Q2Q % growth | -0.10 37.50% | -0.09 | -0.01 | -15.34% |
| Q4 2021 Q2Q % growth | -0.09 55.00% | -0.10 | 0.01 | 5.46% |
| Q3 2021 Q2Q % growth | -0.13 31.58% | -0.15 | 0.02 | 11.49% |
| Q2 2021 Q2Q % growth | -0.14 39.13% | -0.15 | 0.01 | 8.50% |
| Q1 2021 Q2Q % growth | -0.16 33.33% | -0.17 | 0.01 | 5.50% |
| Q4 2020 Q2Q % growth | -0.20 -11.11% | -0.16 | -0.04 | -21.66% |
| Q3 2020 Q2Q % growth | -0.19 | -0.19 | 0.00 | 0.21% |
| Q2 2020 Q2Q % growth | -0.23 8.00% | -0.16 | -0.07 | -43.62% |
| Q1 2020 Q2Q % growth | -0.24 25.00% | -0.13 | -0.11 | -90.52% |
| Q4 2019 Q2Q % growth | -0.18 | -0.18 | 0.00 | -1.49% |
| Q3 2019 Q2Q % growth | -0.19 | -0.23 | 0.04 | 17.84% |
| Q2 2019 Q2Q % growth | -0.25 | -0.29 | 0.04 | 14.64% |
| Q1 2019 Q2Q % growth | -0.32 | -0.32 | 0.00 | 0.72% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 121.984M 13.80% | 125.12M | -3.136M | -2.51% |
| Q1 2025 Q2Q % growth | 114.802M 40.22% | 118.73M | -3.928M | -3.31% |
| Q4 2024 Q2Q % growth | 117.549M 59.06% | 115.06M | 2.489M | 2.16% |
| Q3 2024 Q2Q % growth | 119.839M 78.13% | 107.97M | 11.869M | 10.99% |
| Q2 2024 Q2Q % growth | 107.191M 78.29% | 88.141M | 19.05M | 21.61% |
| Q1 2024 Q2Q % growth | 81.875M 43.86% | 78.821M | 3.054M | 3.87% |
| Q4 2023 Q2Q % growth | 73.904M 47.87% | 73.593M | 310.68K | 0.42% |
| Q3 2023 Q2Q % growth | 67.275M 63.72% | 63.368M | 3.907M | 6.16% |
| Q2 2023 Q2Q % growth | 60.123M 77.30% | 56.61M | 3.513M | 6.21% |
| Q1 2023 Q2Q % growth | 56.914M 95.58% | 54.477M | 2.437M | 4.47% |
| Q4 2022 Q2Q % growth | 49.98M 89.46% | 46.848M | 3.132M | 6.69% |
| Q3 2022 Q2Q % growth | 41.09M 98.69% | 35.174M | 5.916M | 16.82% |
| Q2 2022 Q2Q % growth | 33.91M 90.19% | 32.448M | 1.462M | 4.51% |
| Q1 2022 Q2Q % growth | 29.1M 81.31% | 28.713M | 387K | 1.35% |
| Q4 2021 Q2Q % growth | 26.38M 88.97% | 22.193M | 4.187M | 18.87% |
| Q3 2021 Q2Q % growth | 20.68M 101.17% | 19.1M | 1.58M | 8.27% |
| Q2 2021 Q2Q % growth | 17.83M 128.88% | 16.744M | 1.086M | 6.49% |
| Q1 2021 Q2Q % growth | 16.05M 57.35% | 14.87M | 1.18M | 7.94% |
| Q4 2020 Q2Q % growth | 13.96M 15.95% | 13.167M | 793K | 6.02% |
| Q3 2020 Q2Q % growth | 10.28M 42.38% | 10.159M | 121K | 1.19% |
| Q2 2020 Q2Q % growth | 7.79M 18.75% | 10.784M | -2.994M | -27.76% |
| Q1 2020 Q2Q % growth | 10.2M 188.95% | 11.093M | -893K | -8.05% |
| Q4 2019 Q2Q % growth | 12.04M | 10.599M | 1.441M | 13.60% |
| Q3 2019 Q2Q % growth | 7.22M | 5.653M | 1.567M | 27.72% |
| Q2 2019 Q2Q % growth | 6.56M | 3.409M | 3.151M | 92.43% |
| Q1 2019 Q2Q % growth | 3.53M | 3.28M | 250K | 7.62% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -8% | -14.82% | -5.63% | -13.26% |
| Revenue | 0.53% | 5.1% | -0.02% | 1.37% |